Predictive Factors for the Outcome of Young Children Emotional and/or Behavioral Disorders After Psychotherapeutic Intervention
NCT ID: NCT05820269
Last Updated: 2023-04-19
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
272 participants
OBSERVATIONAL
2009-01-05
2013-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Their prevalence is between 7% and 13% depending on the studies. Behavioral disorders, and to a lesser extent emotional disorders, tend to persist through childhood and adolescence and are a risk factor for disorders in adulthood.
There is still little research on psychotherapies concerning children and even less on parent(s)-young child therapies, despite a certain interest of clinicians for these.
In a previous study, three independent factors appeared predictive of the unfavorable child's outcome : the frequency and intensity of behavioral problems and fears, as well as the absence of the father at more than 2/3 of the consultations. The only independent factor associated with the outcome of the mother was her anxiety score at the start of treatment.
The study presented here will take these elements into account and will include an assessment of both parents.
The main objective is to identify predictive factors of behavioural and emotional disorder outcome in children aged 18 months to 48 months after parent-child psychotherapy. The secondary objectives are to study predictive factors of the outcome in parents (anxiety/depression symptoms) and parent-child relationship.
The main predictive factors will be the presence of the father at the consultations, the therapeutic alliance (subject to validation), the type of disorder of the child and the parental psychopathology.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Paternal Involvement in Psychiatric Care of Adolescents Managed for Depression or Suicide Attempt
NCT03661008
Clinical and Social Trajectories of Children and Adolescents With Disruptive Behavior
NCT02812537
Parental Representations of the Impact of the Use of Screens on Their Preschool Children Health and Development.
NCT03308422
Study of the Psychological Development of Children of Parents With and Without Affective Disorders
NCT00001170
Relationships in Good Hands - Clinical and Cost-effectiveness of Dyadic Developmental Psychotherapy
NCT04187911
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Their prevalence is between 7% and 13% depending on the studies. Behavioral disorders, and to a lesser extent emotional disorders, tend to persist through childhood and adolescence and are a risk factor for disorders in adulthood.
There is still little research on psychotherapies concerning children and even less on parent(s)-young child therapies, despite a certain interest of clinicians for these.
Most studies have shown a significant association between these early childhood disorders and a parent-child relationship disorder, as well as the presence of depressive symptoms in the mother.
Other risk factors include environmental, child and parenting factors.
Several types of therapeutic intervention have been developed in recent decades to treat the difficulties of young children, their common point being to work jointly with the child and the parents and to focus on the parent-child relationship.
From the many studies carried out, we can retain the greatest difficulty in treating behavioral disorders, compared to emotional disorders or functional disorders.
Even if the therapies have shown their effectiveness, a certain number of children continue to present difficulties after the treatment.
The factors most often found associated with poorer progress are the intensity of the child's disorders, the child's advanced age, the presence of parental psychopathology and negative life events.
In young children, other studies are needed to better understand the factors involved in the failure or success of therapy and in particular to determine whether these are the same factors as in older children.
Several early childhood clinicians have insisted on the need for an alliance so that therapeutic work can take place. In particular, they underlined the importance of developing empathy and a positive affective bond between the therapist and the parents. Despite its recognized clinical interest, the therapeutic alliance (or working alliance) has been the subject of little research in populations of young children.
The "Working Alliance Inventory" is a scale measuring the therapeutic alliance differentiates three components: the bond, the tasks and the objectives
In a previous study, three independent factors appeared predictive of the unfavorable future of the child: the frequency and intensity of behavioral problems and fears, as well as the absence of the father at more than 2/3 of the consultations. The only independent factor associated with the outcome of the mother was her anxiety score at the start of treatment.
The study presented here will take these elements into account and will include an assessment of both parents.
The main objective is to identify predictive factors of behavioural and emotional disorder outcome in children aged 18 months to 48 months after parent-child psychotherapy. The main outcome is the Child Beavior Check list (CBCL) total score change.
The secondary objectives are to study predictive factors of the outcome in parents (anxiety/depression symptoms) and parent-child relationship.
Outcomes will be assessed by comparing the pre- and post-therapy scores of a battery of questionnaires that assess the child's symptoms, the parents' anxiety/depression, and the parent-child relationship. Multivariate linear regression analysis will be used to identify, among the studied variables (child age and sex, socio-economic status, life events, disorder type, intensity and duration, social support, parents' psychopathology, parents' attachment, parent-child relationships, therapy length and frequency, father's involvement in the therapy, and therapeutic alliance), predictive factors of the outcomes.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
parents-child psychotherapy
filling out questionnaires during psychotherapy consultations
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* child aged 18 to 48 months at the time of making the appointment for the first consultation
* parents who can speak French
* child presenting as a reason for consultation a behavioral and/or a emotional disorder (anger, opposition, provocation, aggressiveness, hyperactivity, agitation, fits of crying, separation difficulties, exaggerated fears, anxiety, sadness, shyness, withdrawal)
* parents who signed the written consent
* affiliation to a social security scheme
Exclusion Criteria
* child seen only for a diagnostic opinion, with redirection to another service or private for pick-up if needed
* presence of an adult other than the father or mother at the first consultation (apart from a mother-in-law or father-in-law)
* child with a suspected or diagnosed pervasive developmental disorder (according to ICD10, F84 criteria),
* suspicion or diagnosis of physical abuse
* child with a sensory disability or mental retardation already diagnosed
* child referred by a SESSAD, a CAMSP or an assessment center for pervasive disorders of the development
18 Months
48 Months
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Montpellier
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Marie-Joëlle Hervé, PHD
Role: PRINCIPAL_INVESTIGATOR
UH of Montpellier
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
UH of Montpellier
Montpellier, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
8301
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.